Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-21-142052

Director acquired 70 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Drutz David · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-11-19 Exercise or conversion : show line 1 in the form +70 $2.40 $168 17,673 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-11-19 Exercise or conversion : show line 2 in the form Stock Options (option to buy) −70 0 D
Loading xslF345X03/tm2133565-1_4seq1.xml…